IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/3/2026

1. KRG
2. CCHGY
3. PRY:IM
4. PRYMY
5. SPY
6. ALAR
7. CCH:LN
8. META
9. AXTI
10. MIN

Go back to IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026
(NASDAQ: INAB) Delayed: 1.42 --0 (-0%)
Previous Close $1.42    52 Week High $ 
Open $1.46    52 Week Low $ 
Day High $1.46    P/E N/A 
Day Low $1.40    EPS $ 
Volume 18,942